G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptide
Aperçu rapide pour G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptide (ABIN939601)
Antigène
Origine
Source
Application
-
-
Type de proteíne
- Synthetic
-
Séquence
- IWQRGKEEEG VYGFLIEDIR KEVNRASKLK CCVCKKNGAS IGCVAPRCKR
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA1333 antibody,
Alternative Names: KIAA1333 control peptide, KIAA1333 antibody Blocking Peptide, Anti-KIAA1333 Blocking Peptide, Kiaa1333 Blocking Peptide, FLJ20333 Blocking Peptide, G2E3 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
-
Sujet
- KIAA1333 is a probable E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.
-
Poids moléculaire
- 80 kDa
Antigène
-